Literature DB >> 17592523

Increased protein and mRNA expression of endostatin in the ischemic brain tissue of rabbits after middle cerebral artery occlusion.

Heng-Li Tian1, Hao Chen, Yu-Hui Cui, Tao Xu, Liang-Fu Zhou.   

Abstract

OBJECTIVE: To explore the changes of endostatin (a strong anti-angiogenesis factor) and vascular endothelial growth factor (VEGF) in the brain tissues of rabbits following cerebral ischemia induced by middle cerebral artery occlusion (MCAO).
METHODS: Twenty-four New Zealand white rabbits were randomly divided into 5 groups: control (n = 5), sham-operation (n = 4), 2-hour ischemia (n = 5), 24-hour ischemia (n = 5), and 48-hour ischemia (n = 5). The expression of VEGF and endostatin were measured by enzyme-linked immunosorbent assay (ELISA) and immunohistochemistry, respectively. In situ hybridization was used to characterize the expression of mRNA for the endostatin.
RESULTS: Both the protein (at least 50%, P < 0.01) and mRNA (at least 70%, P < 0.05) of endostatin increased significantly in the ischemic brain tissues after MCAO compared with the control group. VEGF increased at least 270% in the brain after cerebral ischemia (P < 0.05).
CONCLUSION: Cerebral ischemia leads to an up-regulation of endostatin in the brain, which is not associated with the increase of VEGF in the brain. The increase of endostatin may serve as a deleterious mechanism for ischemic injury through blocking angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17592523      PMCID: PMC5500774          DOI: 10.1007/s12264-007-0005-2

Source DB:  PubMed          Journal:  Neurosci Bull        ISSN: 1995-8218            Impact factor:   5.203


  29 in total

Review 1.  Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis.

Authors:  D Hanahan; J Folkman
Journal:  Cell       Date:  1996-08-09       Impact factor: 41.582

2.  Endostatin induces endothelial cell apoptosis.

Authors:  M Dhanabal; R Ramchandran; M J Waterman; H Lu; B Knebelmann; M Segal; V P Sukhatme
Journal:  J Biol Chem       Date:  1999-04-23       Impact factor: 5.157

3.  Collateral growth and angiogenesis around cortical stroke.

Authors:  L Wei; J P Erinjeri; C M Rovainen; T A Woolsey
Journal:  Stroke       Date:  2001-09       Impact factor: 7.914

4.  Anti-endostatin monoclonal antibody enhances growth of human hepatocellular carcinoma cells by inhibiting activity of endostatin secreted by the transplanted cells in nude mice.

Authors:  So Tsuboi; Kazuhiro Nouso; Yasuko Tomono; Seishi Nagamori; Ichiro Naito; Tsunakazu Watanabe; Koji Manabe; Hiroyuki Ohmori; Harushige Nakatsukasa; Masahiro Miyazaki; Toshihiro Higashi; Yasushi Shiratori; Masayoshi Namba; Yoshifumi Ninomiya
Journal:  Int J Oncol       Date:  2004-11       Impact factor: 5.650

5.  Endostatin blocks vascular endothelial growth factor-mediated signaling via direct interaction with KDR/Flk-1.

Authors:  Young-Mi Kim; Sewook Hwang; Young-Myoeng Kim; Bo-Jeong Pyun; Tae-Yoon Kim; Seung-Taek Lee; Yong Song Gho; Young-Guen Kwon
Journal:  J Biol Chem       Date:  2002-05-23       Impact factor: 5.157

6.  Differential role of bFGF and VEGF for vasculogenesis.

Authors:  Shohreh Kazemi; Daniela Wenzel; Eugen Kolossov; Nibedita Lenka; Axel Raible; Philipp Sasse; Jürgen Hescheler; Klaus Addicks; Bernd K Fleischmann; Wihelm Bloch
Journal:  Cell Physiol Biochem       Date:  2002

7.  Endostatin inhibits ischemia-induced neovascularization and increases ischemic tissue loss.

Authors:  Michael Dobryansky; Robert D Galiano; Curtis L Cetrulo; Kirit A Bhatt; Joseph Michaels; Russell Ashinoff; Jamie P Levine; Geoffrey C Gurtner
Journal:  Ann Plast Surg       Date:  2004-05       Impact factor: 1.539

8.  Endostatin dramatically inhibits endothelial cell migration, vascular morphogenesis, and perivascular cell recruitment in vivo.

Authors:  Dag K Skovseth; Marjan J T Veuger; Dag R Sorensen; Paula M De Angelis; Guttorm Haraldsen
Journal:  Blood       Date:  2004-10-05       Impact factor: 22.113

9.  VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia.

Authors:  Yunjuan Sun; Kunlin Jin; Lin Xie; Jocelyn Childs; Xiao Ou Mao; Anna Logvinova; David A Greenberg
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

10.  Role of angiogenesis in patients with cerebral ischemic stroke.

Authors:  J Krupinski; J Kaluza; P Kumar; S Kumar; J M Wang
Journal:  Stroke       Date:  1994-09       Impact factor: 7.914

View more
  6 in total

1.  Changes in serum vascular endothelial growth factor and endostatin concentrations associated with circulating endothelial progenitor cells after acute ischemic stroke.

Authors:  Lixia Xue; Hao Chen; Ting Zhang; Jingjiong Chen; Zhi Geng; Yuwu Zhao
Journal:  Metab Brain Dis       Date:  2017-01-16       Impact factor: 3.584

2.  Plasma Endostatin Levels at Acute Phase of Ischemic Stroke Are Associated with Post-Stroke Cognitive Impairment.

Authors:  Sifan Qian; Ruyi Li; Chenhuan Zhang; Rui Zhang; Daoxia Guo; Xiaoqing Bu; Aili Wang; Hao Peng; Jing Chen; Yonghong Zhang; Jiang He; Tan Xu; Chongke Zhong
Journal:  Neurotox Res       Date:  2020-02-08       Impact factor: 3.911

3.  Endostatin binds nerve growth factor and thereby inhibits neurite outgrowth and neuronal migration in-vitro.

Authors:  Abraham Al Ahmad; Boyeon Lee; Jonathan Stack; Christi Parham; Joel Campbell; Douglas Clarke; Andrzej Fertala; Gregory J Bix
Journal:  Brain Res       Date:  2010-09-21       Impact factor: 3.252

Review 4.  Axon guidance factor netrin-1 and its receptors regulate angiogenesis after cerebral ischemia.

Authors:  Qiao Ding; Song-Jie Liao; Jian Yu
Journal:  Neurosci Bull       Date:  2014-05-30       Impact factor: 5.203

Review 5.  Perlecan domain V therapy for stroke: a beacon of hope?

Authors:  Gregory J Bix
Journal:  ACS Chem Neurosci       Date:  2012-12-24       Impact factor: 4.418

6.  Endostatin as a Mediator Between Endothelial Function and Cognitive Performance in Those at Risk for Vascular Cognitive Impairment.

Authors:  Cameron Isaacs-Trepanier; Mahwesh Saleem; Nathan Herrmann; Walter Swardfager; Paul I Oh; Benjamin I Goldstein; Jane Mitchell; Kim S Sugamori; Krista L Lanctôt
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.